Events

Tyler Merkeley GTCbio’s 14th Anti-Infectives Partnering & Deal-Making What to expect from CARB-X in our 2nd year of "Xccelerating Global Antibacterial Innovation" Baltimore, MD 13-14 July 201

Heather Shane CARB-X, California Life Sciences Institute and BioLabs Introduction to CARB-X, Panel Discussion with Forge and Cidara San Diego, CA 18 Jul 2017

John Rex CARB-XED, GARDP, ASM, and ESCMID CARB-XED Workshop: Antibiotic Development Bootcamp – Join John Rex for a pre-conference workshop at the 2017 ASM/ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance. Boston, MA 5 Sep 2017

Kevin Outterson, Joe Larsen & Tim Jinks DRIVE-AB DRIVE-AB Final Conference: Revitalizing the antibiotic pipeline Crowne Plaza, Brussels 5-6 Sep 2017

John Rex ASM-ESCMID ASM-ESCMID Conference on Drug Development to Meet the Challenge of Antimicrobial Resistance Boston, MA 6-8 Sep 2017

Tyler Merkeley G20 G20 Antibiotic R&D Hub Meeting Berlin 11-12 Sep 2017

Barry Eisenstein & John Rex FDA-CDRH FDA-CDRH workshop on diagnostic devices for detecting antimicrobial susceptibility & resistance FDA - Silver Spring, MD 13 Sep 2017

Tyler Merkeley & Christopher Houchens 3rd World Antimicrobial Resistance Congress Accelerating a diverse global portfolio of 20 innovative antibacterial products towards clinical development leveraging a public private partnership model Washington, DC 14-15 Sep 2017

Tyler Merkeley, Kevin Outterson & Dennis Dixon Panel: Non-Dilutive Funding and Other Unique Capital Sources McDermott, Will & Emery Life Sciences Dealmaking Symposium Royal Sonesta Boston Cambridge, MA 4 Oct 2017

Kevin Outterson IHSIP Forces Shaping the Future of Health & Healthcare Boston, MA 16 Oct 2017